MétaCan
Menu
Back to cohort
Record W2588612590 · doi:10.1093/neuonc/now212.293

EXTH-51. BREVICAN-SPECIFIC PEPTIDES FOR THE DEVELOPMENT OF NEXT-GENERATION TARGETED THERANOSTICS FOR MALIGNANT GLIOMAS

2016· article· en· W2588612590 on OpenAlexaff
Choi‐Fong Cho, Kazue Kasai, Justin M. Wolfe, Kalvis Hornburg, Fernanda C. Bononi, Leonard G. Luyt, Bradley L. Pentelute, Mariano S. Viapiano, E. Antonio Chiocca, Sean Lawler

Bibliographic record

VenueNeuro-Oncology · 2016
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicUbiquitin and proteasome pathways
Canadian institutionsWestern University
Fundersnot available
KeywordsGliomaFlow cytometryPeptide libraryPeptideCancer researchCancer cellBiologyMolecular biologyChemistryCancerBiochemistryPeptide sequenceGene

Abstract

fetched live from OpenAlex

High-grade gliomas are deadly cancers, and current standard-of-care has demonstrated limited success. The ability to specifically target glioma cells can allow for the development of improved theranostic agents leading to better detection methods and safer anti-cancer therapies. Brevican (BCAN), a CNS-specific extracellular matrix protein is upregulated in glioma cells and its expression correlates with tumor progression. Particularly, a plasma membrane bound BCAN isoform lacking normal glycosylation, called B/bΔg is a unique glioma marker and is not expressed in non-cancerous tissues. Therefore, B/bΔg represents a valuable target for anti-cancer strategies. We describe here the discovery of novel high-affinity B/bΔg-Targeted Peptides (BTP) using rapid combinatorial library screens. Briefly, a one-bead-one-compound (OBOC) peptide library was screened against small magnetic particles decorated with B/bΔg. Positive “hit” beads labeled with magnetic particles were isolated using a high-throughput in-house microfluidic magnetic-activated sorter of our own design. These hits were exposed to cells expressing B/bΔg, and beads/peptides with the highest cell association were isolated and sequenced. Seven novel peptides were identified. Cell uptake and blocking studies revealed that 5 of these peptides displayed specific affinity for B/bΔg-overexpressing cells. These candidates displayed nano-/micromolar binding affinity for recombinant B/bΔg protein. Further analyses of these candidates using confocal microscopy revealed increased peptide binding/uptake in patient-derived glioma stem cells compared with primary human astrocytes. Flow cytometry analysis using GBM-X6 cells revealed BTP-2, 7 and 8 as the top three candidates. For in vivo evaluation, GBM-X6 tumors were established intracranially in nude mice, and tumor formation was verified by magnetic resonance imaging. We observed that upon systemic administration, BTP-7 displayed the highest and most rapid tumor uptake, followed by BTP-2 and then, BTP-8. Our data here provides strong evidence that these peptides can serve as tumor-specific agents, and offer substantial promise in the development of highly efficacious and safe brain cancer therapeutics.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.070
GPT teacher head0.291
Teacher spread0.221 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicUbiquitin and proteasome pathwaysFrench-language works237,207